Product Information
ARIPIPRAZOLE 30 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.1670 per EA under NDC 43547030703. Its NADAC has been published 420 times since Jun 13, 2018.
Strength
30 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547030703
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA205363On Market Since
9/15/2017
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 30 MG TABLET has been published 420 times since Jun 13, 2018, and over the history we have for it it has declined 72.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1670 per EA |
|---|---|
| All-time high | $0.6248 (Sep 12, 2018) |
| All-time low | $0.1365 (Nov 20, 2024) |
| 52-week high | $0.1829 |
| 52-week low | $0.1670 |
| Median price | $0.2760 |
| Average price | $0.3008 |
| Largest weekly change | +41.4% (Aug 21, 2024) |
| Weeks tracked | 420 |
| Tracking since | Jun 13, 2018 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 30 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.1670 per EA (NDC 43547030703), effective Jun 24, 2026.
How has the price of ARIPIPRAZOLE 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 30 MG TABLET has declined 72.6%. It has been tracked across 420 weekly CMS publications since Jun 13, 2018.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 30 MG TABLET?
Since Jun 13, 2018, the NADAC for ARIPIPRAZOLE 30 MG TABLET has ranged from a low of $0.1365 (Nov 20, 2024) to a high of $0.6248 (Sep 12, 2018), with a median of $0.2760 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE 30 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ARIPIPRAZOLE 30 MG TABLET, but none are currently priced below it.
Who manufactures ARIPIPRAZOLE 30 MG TABLET?
ARIPIPRAZOLE 30 MG TABLET (NDC 43547030703) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification